vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and LandBridge Co LLC (LB). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $51.0M, roughly 1.2× LandBridge Co LLC). LandBridge Co LLC runs the higher net margin — 35.0% vs -70.9%, a 106.0% gap on every dollar of revenue. On growth, LandBridge Co LLC posted the faster year-over-year revenue change (16.0% vs 8.1%). LandBridge Co LLC produced more free cash flow last quarter ($40.9M vs $-1.8M). Over the past eight quarters, LandBridge Co LLC's revenue compounded faster (40.2% CAGR vs 17.7%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
CTKB vs LB — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $51.0M |
| Net Profit | $-44.1M | $17.9M |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | 57.2% |
| Net Margin | -70.9% | 35.0% |
| Revenue YoY | 8.1% | 16.0% |
| Net Profit YoY | -557.1% | 15.6% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $51.0M | ||
| Q4 25 | $62.1M | $56.8M | ||
| Q3 25 | $52.3M | $50.8M | ||
| Q2 25 | $45.6M | $47.5M | ||
| Q1 25 | $41.5M | $44.0M | ||
| Q4 24 | $57.5M | $36.5M | ||
| Q3 24 | $51.5M | $28.5M | ||
| Q2 24 | $46.6M | $26.0M |
| Q1 26 | — | $17.9M | ||
| Q4 25 | $-44.1M | $8.1M | ||
| Q3 25 | $-5.5M | $8.1M | ||
| Q2 25 | $-5.6M | $7.5M | ||
| Q1 25 | $-11.4M | $6.5M | ||
| Q4 24 | $9.6M | $49.3M | ||
| Q3 24 | $941.0K | $2.7M | ||
| Q2 24 | $-10.4M | $-57.7M |
| Q1 26 | — | — | ||
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — |
| Q1 26 | — | 57.2% | ||
| Q4 25 | -9.0% | 60.0% | ||
| Q3 25 | -17.6% | 60.8% | ||
| Q2 25 | -23.3% | 60.0% | ||
| Q1 25 | -36.1% | 57.0% | ||
| Q4 24 | 5.2% | 49.4% | ||
| Q3 24 | -8.2% | 11.2% | ||
| Q2 24 | -18.3% | -197.4% |
| Q1 26 | — | 35.0% | ||
| Q4 25 | -70.9% | 14.2% | ||
| Q3 25 | -10.5% | 15.9% | ||
| Q2 25 | -12.2% | 15.8% | ||
| Q1 25 | -27.5% | 14.7% | ||
| Q4 24 | 16.8% | 135.2% | ||
| Q3 24 | 1.8% | 9.3% | ||
| Q2 24 | -22.4% | -222.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | $0.24 | ||
| Q3 25 | — | $0.26 | ||
| Q2 25 | — | $0.24 | ||
| Q1 25 | — | $0.20 | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-0.04 | ||
| Q2 24 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $29.7M |
| Total DebtLower is stronger | — | $433.0K |
| Stockholders' EquityBook value | $341.7M | — |
| Total Assets | $461.5M | $1.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $29.7M | ||
| Q4 25 | $90.9M | $30.7M | ||
| Q3 25 | $93.3M | $28.3M | ||
| Q2 25 | $75.5M | $20.3M | ||
| Q1 25 | $95.3M | $14.9M | ||
| Q4 24 | $98.7M | $37.0M | ||
| Q3 24 | $162.3M | $14.4M | ||
| Q2 24 | $177.9M | $24.6M |
| Q1 26 | — | $433.0K | ||
| Q4 25 | — | $570.7M | ||
| Q3 25 | — | $366.1M | ||
| Q2 25 | — | $370.9M | ||
| Q1 25 | — | $375.5M | ||
| Q4 24 | — | $385.5M | ||
| Q3 24 | — | $242.4M | ||
| Q2 24 | — | $360.8M |
| Q1 26 | — | — | ||
| Q4 25 | $341.7M | $340.3M | ||
| Q3 25 | $378.6M | $272.0M | ||
| Q2 25 | $377.6M | $266.4M | ||
| Q1 25 | $379.6M | $217.0M | ||
| Q4 24 | $395.7M | $211.8M | ||
| Q3 24 | $385.5M | $97.2M | ||
| Q2 24 | $389.1M | $296.4M |
| Q1 26 | — | $1.4B | ||
| Q4 25 | $461.5M | $1.4B | ||
| Q3 25 | $494.9M | $1.1B | ||
| Q2 25 | $493.3M | $1.1B | ||
| Q1 25 | $482.6M | $1.0B | ||
| Q4 24 | $499.5M | $1.0B | ||
| Q3 24 | $491.2M | $689.9M | ||
| Q2 24 | $483.7M | $710.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.68× | ||
| Q3 25 | — | 1.35× | ||
| Q2 25 | — | 1.39× | ||
| Q1 25 | — | 1.73× | ||
| Q4 24 | — | 1.82× | ||
| Q3 24 | — | 2.49× | ||
| Q2 24 | — | 1.22× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $41.1M |
| Free Cash FlowOCF − Capex | $-1.8M | $40.9M |
| FCF MarginFCF / Revenue | -2.9% | 80.3% |
| Capex IntensityCapex / Revenue | 1.6% | — |
| Cash ConversionOCF / Net Profit | — | 2.30× |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $232.8M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $41.1M | ||
| Q4 25 | $-771.0K | $126.3M | ||
| Q3 25 | $-3.9M | $34.9M | ||
| Q2 25 | $108.0K | $37.3M | ||
| Q1 25 | $-125.0K | $15.9M | ||
| Q4 24 | $2.0M | $67.6M | ||
| Q3 24 | $13.2M | $7.5M | ||
| Q2 24 | $6.2M | $16.0M |
| Q1 26 | — | $40.9M | ||
| Q4 25 | $-1.8M | $122.0M | ||
| Q3 25 | $-4.6M | $33.7M | ||
| Q2 25 | $-1.5M | $36.1M | ||
| Q1 25 | $-974.0K | $15.8M | ||
| Q4 24 | $1.1M | $66.7M | ||
| Q3 24 | $12.2M | $7.1M | ||
| Q2 24 | $5.2M | $15.7M |
| Q1 26 | — | 80.3% | ||
| Q4 25 | -2.9% | 214.9% | ||
| Q3 25 | -8.7% | 66.3% | ||
| Q2 25 | -3.2% | 75.9% | ||
| Q1 25 | -2.3% | 36.0% | ||
| Q4 24 | 1.9% | 182.6% | ||
| Q3 24 | 23.7% | 25.1% | ||
| Q2 24 | 11.0% | 60.4% |
| Q1 26 | — | — | ||
| Q4 25 | 1.6% | 7.5% | ||
| Q3 25 | 1.3% | 2.3% | ||
| Q2 25 | 3.5% | 2.6% | ||
| Q1 25 | 2.0% | 0.2% | ||
| Q4 24 | 1.6% | 2.7% | ||
| Q3 24 | 2.0% | 1.1% | ||
| Q2 24 | 2.3% | 1.4% |
| Q1 26 | — | 2.30× | ||
| Q4 25 | — | 15.68× | ||
| Q3 25 | — | 4.31× | ||
| Q2 25 | — | 4.98× | ||
| Q1 25 | — | 2.46× | ||
| Q4 24 | 0.21× | 1.37× | ||
| Q3 24 | 14.05× | 2.80× | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
LB
| Other | $14.2M | 28% |
| Easements and other surface-related revenues | $11.6M | 23% |
| Surface use royalties - related party | $11.0M | 22% |
| Resource sales | $5.2M | 10% |
| Resource royalties | $4.3M | 8% |
| Easements and other surface-related revenues - related party | $3.2M | 6% |
| Resource royalties - related party | $1.3M | 2% |
| Resource sales - related party | $205.0K | 0% |
